CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale Director sold 10,000 shares at $4.77 ($47,700)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Open-market sale Director sold 10,000 shares at $6.91 ($69,100)
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 8-K Event Material agreement · Other events
- 4 Open-market sale Director sold 10,000 shares at $5.86 ($58,600)
- 4 Open-market sale Director sold 10,000 shares at $5.33 ($53,300)
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 4 Open-market sale Director sold 10,000 shares at $4.64 ($46,400)
Page 21 of 44 · 872 filings